newsfilter
← Latest News
GlobeNewswire·

Dianthus Therapeutics to Participate in Three Investor Conferences During September

NEW YORK and WALTHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (NASDAQ:DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the